Inaugural Circulating Cell-Free DNA

Circulating cell-free DNA's most obvious applications are in cancer detection and monitoring. However, it also provides a non-invasive diagnostic solution for a wide range of clinical disorders. Cambridge Healthtech Institute's Inaugural Circulating Cell-Free DNA symposium will examine applications in cancer, prenatal diagnostics, cardiovascular disease and organ transplant monitoring.

Molecular counting technologies, including digital PCR and next-generation sequencing, will be evaluated and new technologies and techniques will be showcased. Special focus will be given to clinical case studies to further explore the applications and potential of circulating cell-free DNA in diagnostics.